The cell membrane is a biological boundary that separates the interior of cells from the extracellular environments. While small non-polar molecules readily cross cell membranes, the cell membrane precludes the passage of most macromolecules, including proteins, DNAs, and RNAs. However, basic cell-penetrating peptides (CPPs) can enter cells, and can co-transport an array of normally impermeable molecules into cells. In this report, we identified factors that determine the mechanisms of CPPs entry. Three arginine-rich CPPs (R9,
Introduction
The cell membrane, composed of a bilayer of phospholipids and proteins, provides a selectively permeable hydrophobic barrier that isolates the cell from the hostile extracellular environment. Membrane permeability depends on the size and polarity of substances, as well as the existence of specific intrinsic membrane transporters. In general, macromolecules, such as proteins and DNAs, are unable to cross cell membranes. Instead, various endocytic pathways, including lipid raft-dependent processes, provide the major routes for cellular entry of exogenous macromolecules. 1 Thus, the cell membrane is a gate that controls the movement of materials in and out of cells. The membrane is also involved in numerous cellular processes, such as signal transduction, cellular potential maintenance, nucleation of multiple protein complexes, and cytoskeleton anchoring. Transport of molecules across the membrane is quite complex as it is affected by the phospholipid, glycolipid, cholesterol, and protein composition of the membrane. Cellular entry processes are also species dependent. 1 In 1988, transactivator of transcription (Tat) protein from the human immunodeficiency virus type 1 (HIV-1) was shown to be capable of overcoming the hydrophobic barrier of the plasma membrane during cellular internalization of molecules. 2, 3 The domain in the Tat protein that mediates cellular entry contains 11 amino acids (YGRKKRRQRRR), and the number of basic residues was thought to correlate with its efficiency of membrane penetration. 4, 5 Subsequently, short peptides derived from the key domain in the Tat protein that mediates membrane penetration were synthesized and tested. These peptides were termed cell-penetrating peptides (CPPs) or protein transduction domains (PTDs). 4 CPPs can be classified into three groups:
protein-derived peptides, model peptides, and designed peptides. 6 Tat is an example of protein-derived CPP. Peptides with repeat motifs or poly-residues are model CPPs. The amphipathic peptide MPG is an example of a designed CPP insofar as it is a chimeric protein containing domains from multiple peptides. 6 Studies have demonstrated that model CPPs containing nona-arginine (R9) residues are 20-fold more efficient at transduction. 7, 8 Moreover, CPPs are efficient shuttles of cargoes, such as proteins, nucleic acids, nanoparticles, and liposomes. These cargoes maintain their biological activities after being transported into cells. 9, 10 The size of the cargoes can be up to 200 nm in diameter. 11 The internalization kinetics of CPPs is rapid, with a first-order rate constant of 0.007 sec -1 , with no toxicity observed at concentrations up to 100 μM.
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Despite many studies using various biological and biophysical techniques, our understanding of the mechanisms of CPP entry remains incomplete and controversial. Low temperature reduced sulfated proteoglycans on cell surface that are involved in endocytosis, but did not stop the internalization of CPPs. 5 Their data further suggested that CPPs enter cells by an energy-independent pathway. Additional studies indicated that CPPs enter cells via clathrin-, caveolin-dependent endocytosis, or actin-dependent macropinocytosis. [13] [14] [15] [16] [17] [18] [19] [20] Compositions of CPPs, types of cells, nature of cargoes, and organisms are factors that might influence the cellular uptake mechanisms. [13] [14] [15] [16] [17] [18] [19] [20] Previously, we demonstrated that arginine-rich CPPs, such as R9, can deliver biologically active macromolecules into different kinds of cells and species following covalent, noncovalent, or combined covalent and noncovalent association. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Our data suggested that internalization of CPPs covalently linked with cargoes, such as R9-green fluorescent protein (GFP) fusion protein, was neither clathrin-dependent nor caveolae-dependent. 21 In certain types of cells, macropinocytosis was the major route of entry when CPP and cargo were associated noncovalently. [24] [25] [26] [27] [28] In some cases, penetration of CPPs with their cargoes was mediated by multiple pathways. 29, 30, 32, 34 In this report, we investigate transduction efficiency of various types of CPPs, cargoes, and types of cells from various organisms. Pharmacological and physical modulators of endocytosis were used to identify the molecular mechanisms of cellular entry. We identify multiple factors that influence the preferred mechanism of cellular uptake of CPP/cargo complexes.
Materials and Methods

Plasmid construction and protein preparation
We constructed a pR9 plasmid containing a hexa-histidine (6His) and an R9 sequence under the control of the T7 promoter, and a pR9-GFP plasmid containing an additional coding region of GFP as previously described. 21 A pQE8-GFP plasmid containing the coding sequence of GFP under the control of the T5 promoter was kindly provided by Dr. Michael B. Elowitz (Rockefeller University, NY, USA). 21 The pHBT-sGFP(S65T)-NOS plasmid (GenBank Accession No. EF090408) containing an engineered GFP gene under the control of the 35S cauliflower mosaic virus enhancer fused to the basal promoter of the maize C4PPDK gene was kindly provided by Dr. Jen Sheen (Harvard University, MA, USA). 25 Plasmid DNA was purified using a Nucleobond AX100 Kit (Machery-Nagel, Duren, Germany). All constructions were verified by DNA sequencing.
For protein expression, pR9, pR9-GFP, and pQE8-GFP plasmids were transformed into Escherichia coli and induced as previously described. 39 Expressed proteins were then purified, concentrated and quantified using a Protein Assay Kit (Bio-Rad, Hercules, CA, USA).
Both synthetic nona-arginine (SR9) and histidine-modified nona-arginine (HR9) peptides (MDBio, Taipei, Taiwan) with more than 95% purity were described previously. 24, 35 Quantum dots (QDs) with green fluorescent emission at 525 nm were composed of CdSe/ZnS core-shell and carboxyl-functionalized groups on surface (eFluor 525NC, eBioscience, San Diego, CA, USA). A series of concentrations of SR9 or HR9 were premixed with QDs and then incubated at 37°C for 2 h. The optimal molecular ratio of 60 was used in subsequent experiments.
Cell culture
Human A549 lung cancer cells (American Type Culture Collection, Manassas, VA, USA; CCL-185) were grown in Roswell Park Memorial Institute (RPMI) 1640 medium (BioWest, Nuaille, France) supplemented with 10% heat inactivated (56°C for 30 min) bovine serum (Gibco, Invitrogen, Carlsbad, CA, USA). Cells were cultured in a humidified 5% CO 2 and 95% air incubator at 37°C as previously described. 26 For plant sample, root-tip cells of mung bean (Vigna radiata L.) were prepared as previously described. 25 For cyanobacteria (blue-green algae) culture, both Synechocystis sp. PCC 6803 (American Type Culture Collection, 27184) and Synechococcus elongatus PCC 7942 (ATCC, 33912) (kindly provided by Dr. Yuh-Jang Shieh, Academia Sinica, Taipei, Taiwan) were grown in BG-11 medium with mild shaking at 50 rpm and regular illumination at 28°C. 28 
Protein transduction and treatment of endocytic modulators
For covalent protein transduction, A549 cells were treated with phosphate buffered saline (PBS), GFP, or R9-GFP for 30 min at 37°C, followed by treatment of Hoechst 33342 (Invitrogen, Carlsbad, CA, USA) as previously described. 35 In the investigation of noncovalent protein transduction, R9 or SR9 peptide was mixed with GFP at a molecular ratio of 3:1 at room temperature for 10 min. All kinds of cells and organisms treated with R9/GFP noncovalent mixtures were described previously. 25, 26, 28 SR9 peptide was mixed with plasmid DNA at a nitrogen/phosphate (N/P) ratio of 3 for 30 min, then transferred to another eppendorf tube and incubated with plant cells. After incubation for 30 min, SR9/DNA mixtures were removed by washing with double deionized water. 25 Plant cells were placed on slides after 48 h of treatment and observed under the microscope. In protein transduction tests, 100 nM QDs were premixed with 6 μM SR9 and HR9, respectively for 2 h with shaking as previous described. 35 Then, these complexes were incubated with cells at 37°C CO 2 incubator for 30 min.
A suite of endocytic modulators and physical procedures were used to study mechanisms of internalization. For energy-dependent experiments at 4°C, the protocol of protein transduction was the same as above except that all incubations were performed at 4°C. Cells were preincubated at 4°C for 30 min before being incubated with the protein transduction solution. 
Confocal microscopy
Images were observed using an inverted TMS microscope (Nikon, Melville, NY, USA) equipped with a MD130 CMOS sensor (Electronic Eyepiece, Dar-An, Taiwan) or an Eclipse E600 microscope (Nikon) and recorded using a Penguin 150CL cooled CCD camera (Pixera, Los Gatos, CA, USA). Bright-field, GFP, and blue fluorescent protein (BFP) images were recorded using a BD Pathway 435 System (BD Biosciences, Franklin Lakes, NJ, USA) as previously described. 35 Excitation filters were set at 377/50 and 482/35 nm for blue and green fluorescence, respectively. Emission filters were set at 435LP (long-pass) and 536/40 nm for BFP and GFP channels, respectively. Transmitted light without the excitation filter, but with 536/40 nm emission filter, was used to observe cell morphology as bright-field images. Fluorescent images were acquired by the TCS SL confocal microscope system (Leica, Wetzlar, Germany), and relative intensities of fluorescent images were quantified by the UN-SCAN-IT software (Silk Scientific, Orem, UT, USA) as previously described. 
Flow cytometric analysis
Cells in the control and the experimental groups were harvested and analyzed using a Cytomics FC500 Flow Cytometer (Beckman Coulter, Fullerton, CA,
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Betty Revon Liu et al USA) as previously described. 28 In brief, FL1 filter (excitation 488 nm and emission 515-545 nm) was used for GFP detection. Samples were counted and analyzed by the CXP software.
Statistical analysis
Results were expressed as mean ± standard deviation (SD). Mean values and SDs were calculated from at least three independent experiments carried out in triplicates per treated group. Statistical comparisons between the control and treated groups were performed by the Student's t-test. The levels of statistical significance were set at P < 0.05 (*) and P < 0.01 (**).
Results
The mechanism of transmembrane delivery of protein by R9
To assess whether arginine-rich CPPs can deliver protein into live cells, human A549 cells were treated with PBS as a control, or R9-GFP fusion protein without fixation followed by treatment with Hoechst 33342. No green signal was observed in the cells treated with PBS as a negative control (Fig. 1) or GFP alone (data not shown) using a BD Pathway 435 System. In contrast, green fluorescence was visible in the cells treated with R9-GFP. Merged images revealed R9-GFP association with the nucleus. These results indicate that R9 peptide mediates the translocation of GFP cargo protein. Fig. 1 . Cellular entry of R9-GFP into A549 cells. Cells were treated with PBS (control) or 30 μM of R9-GFP for 30 min at 37°C, followed by treatment of Hoechst 33342, as previously described. 35 GFP fluorescence indicates the location of CPP, while the BFP signal shows the location of the nucleus. Images of bright-field, GFP, and BFP channels are shown using a BD Pathway 435 system.
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Discussion
In pharmacology, endosome forming disrupting drugs (valinomycin and nigericin), a metabolism depression drug (sodium azide), and generally endocytic inhibitors (NEM and 4°C) were thought to interfere with the classical endocytosis. [41] [42] [43] Our data demonstrate that arginine-rich CPP/cargo complexes enter cells through macropinocytosis, direct membrane translocation, or multiple endocytic pathways (Fig. 2-4) . Direct membrane translocation is an energy-independent pathway, including pore formation, inverted micelle formation, carpet-like perturbation, and membrane thinning model. 44, 45 It is generally observed only at high CPP concentrations or with primary amphipathic CPPs. 46 However, we reason that HR9 penetrate cells by pore formation because of the imidazole functional group on its histidine residues. 35 Endocytosis is classified into two categories: phagocytosis that involves the uptake of large particles and pinocytosis that involves solute uptake. 44 Macropinocytosis, clathrin-dependent, caveolin-dependent, and clathrin/caveolin-independent pathways are forms of pinocytosis. 47 Many factors affect the route and efficiency of cellular uptake. With CPPs, number of positive charges, conformation, length of the peptide, hydrophobicities, and concentration influence the uptake. 44 Recently, both arginine length of CPP and hydrophobicity of cargo were proven to be important factors for direct membrane translocation. 48, 49 In CPP-mediated co-transport, the nature of cargo, cargo size, and method of cargo/CPP association determine the preferred translocation mechanism. 44, 48 Our studies also provided the evidence that factors, such as cell types, temperature, and incubation time, influence the uptake mechanism. 44, [48] [49] [50] Arginine-rich CPPs are very attractive, nontoxic candidates for the delivery of bio-imaging and therapeutic macromolecules, such as QDs, proteins, and nucleic acids. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Their safety has been confirmed by metabolic analysis. 51 In the present study, we have used pharmacological modulators and physical treatments to demonstrate that arginine-rich CPP/cargoes can be internalized via macropinocytosis, direct membrane translocation, or a combination of multiple pathways. The specific route of internalization is influenced by the nature of the CPP, the nature of the cargo, and the nature of the CPP/cargo association.
Conclusion
In this study, we demonstrated that types of CPPs and cargoes are two primary factors in determining the mechanisms of transmembrane delivery. All of mammalian cells, plant cells, and cyanobacteria were sensitive with varying degrees to macropinocytosis inhibitors EIPA and CytD, indicating that macropinocytosis is a route for R9/GFP internalization. Our data suggested that different arginine-rich CPPs (SR9 and HR9) carrying the same cargoes (QDs) induce different responses of membrane action. While SR9/QD entered mammalian cells via multiple pathways, the uptake of HR9/QD was a direct membrane translocation in an energy-independent manner. In the case of the same CPPs, R9/GFP crossed membranes by macropinocytosis while the cellular uptake mechanism of R9/DNA was a combination of multiple pathways.
